Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FVRR Fiverr International	$23.15 -1.7%	$25.00	$20.83 ▼ $36.11	$844.13M	1.35	917,874 shs	437,158 shs
NEO NeoGenomics	$8.81 +0.3%	$6.66	$4.72 ▼ $19.11	$1.13B	1.62	2.13 million shs	5.66 million shs
NVRI Enviri	$10.99 -2.8%	$9.48	$4.72 ▼ $11.90	$911.32M	1.89	1.28 million shs	1.54 million shs
OABI OmniAb	$1.58 -1.3%	$1.90	$1.22 ▼ $4.87	$196.32M	0.14	465,958 shs	232,440 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FVRR Fiverr International	0.00%	+0.43%	+6.65%	-27.93%	-5.27%
NEO NeoGenomics	0.00%	+36.12%	+70.16%	+17.38%	-46.85%
NVRI Enviri	0.00%	+0.23%	+30.87%	+37.49%	-5.60%
OABI OmniAb	0.00%	-1.84%	-16.23%	+16.79%	-61.81%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FVRR Fiverr International	3.7696 of 5 stars	4.3	1.0	2.8	1.7	2.5
NEO NeoGenomics	3.3465 of 5 stars	4.2	3.0	2.7	1.7	0.6
NVRI Enviri	0.4028 of 5 stars	1.0	1.0	3.1	1.7	0.0
OABI OmniAb	2.4872 of 5 stars	3.5	0.0	3.3	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FVRR Fiverr International	2.50	Moderate Buy	$33.13	43.09% Upside
NEO NeoGenomics	2.38	Hold	$13.22	50.08% Upside
NVRI Enviri	2.00	Hold	$10.00	-8.97% Downside
OABI OmniAb	3.00	Buy	$6.67	321.94% Upside

Current Analyst Ratings Breakdown

Latest OABI, NVRI, NEO, and FVRR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2025	NEO NeoGenomics	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$6.50 ➝ $11.00
8/29/2025	NEO NeoGenomics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.00 ➝ $14.00
8/7/2025	OABI OmniAb	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$4.00 ➝ $3.00
8/4/2025	NEO NeoGenomics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$12.00 ➝ $11.00
7/31/2025	FVRR Fiverr International	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $33.00
7/31/2025	FVRR Fiverr International	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$35.00 ➝ $28.00
7/31/2025	FVRR Fiverr International	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$32.00 ➝ $25.00
7/31/2025	FVRR Fiverr International	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$32.00 ➝ $30.00
7/31/2025	FVRR Fiverr International	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$36.00 ➝ $32.00
7/30/2025	NEO NeoGenomics	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$10.00 ➝ $8.00
7/30/2025	NEO NeoGenomics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral

(Data available from 9/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FVRR Fiverr International	$391.48M	2.12	$1.23 per share	18.77	$11.30 per share	2.05
NEO NeoGenomics	$660.57M	1.72	$0.44 per share	20.01	$6.61 per share	1.33
NVRI Enviri	$2.34B	0.38	$2.12 per share	5.19	$5.18 per share	2.12
OABI OmniAb	$26.39M	7.35	N/A	N/A	$2.14 per share	0.74

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FVRR Fiverr International	$18.25M	$0.48	48.23	18.52	N/A	4.34%	11.87%	4.01%	10/29/2025 (Estimated)
NEO NeoGenomics	-$78.73M	-$0.81	N/A	97.89	N/A	-15.10%	-2.72%	-1.54%	11/4/2025 (Estimated)
NVRI Enviri	-$127.97M	-$1.96	N/A	∞	N/A	-7.02%	-7.86%	-1.33%	10/30/2025 (Estimated)
OABI OmniAb	-$62.03M	-$0.60	N/A	N/A	N/A	-275.83%	-22.79%	-20.18%	11/11/2025 (Estimated)

Latest OABI, NVRI, NEO, and FVRR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	OABI OmniAb	-$0.14	-$0.15	-$0.01	-$0.15	$5.33 million	$3.90 million
8/5/2025	Q2 2025	NVRI Enviri	-$0.11	-$0.22	-$0.11	-$0.59	$576.50 million	$562.25 million
7/30/2025	Q2 2025	FVRR Fiverr International	$0.72	$0.69	-$0.03	$0.09	$107.75 million	$108.65 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FVRR Fiverr International	N/A	N/A	N/A	N/A	N/A
NEO NeoGenomics	N/A	N/A	N/A	N/A	N/A
NVRI Enviri	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FVRR Fiverr International	0.07	1.32	1.32
NEO NeoGenomics	0.40	3.92	3.58
NVRI Enviri	3.55	1.19	0.88
OABI OmniAb	N/A	3.77	3.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FVRR Fiverr International	59.00%
NEO NeoGenomics	98.50%
NVRI Enviri	93.43%
OABI OmniAb	72.08%

Insider Ownership

Company	Insider Ownership
FVRR Fiverr International	15.90%
NEO NeoGenomics	2.40%
NVRI Enviri	2.50%
OABI OmniAb	8.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FVRR Fiverr International	790	35.84 million	30.15 million	Optionable
NEO NeoGenomics	2,200	129.18 million	126.08 million	Optionable
NVRI Enviri	12,000	80.65 million	78.63 million	Optionable
OABI OmniAb	7	122.70 million	112.15 million	Optionable

OABI, NVRI, NEO, and FVRR Headlines

Recent News About These Companies

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

September 2 at 9:54 AM | finance.yahoo.com

OmniAb, Inc. $OABI Shares Sold by First Sabrepoint Capital Management LP

September 2 at 7:53 AM | marketbeat.com

OmniAb stock falls after announcing $30 million private placement

August 27, 2025 | za.investing.com

Deutsche Bank AG Reduces Stock Position in OmniAb, Inc. $OABI

August 27, 2025 | marketbeat.com

OmniAb to raise $30M in private stock placement

August 25, 2025 | msn.com

OmniAb Announces $30 Million Private Placement

August 25, 2025 | businesswire.com

OmniAb (OABI) Gets a Buy from Craig-Hallum

August 12, 2025 | theglobeandmail.com

OmniAb (NASDAQ:OABI) Price Target Lowered to $3.00 at Royal Bank Of Canada

August 8, 2025 | marketbeat.com

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

August 7, 2025 | seekingalpha.com

OmniAb Inc (OABI) Q2 2025 Earnings Report Preview: What To Expect

August 6, 2025 | finance.yahoo.com

OmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue Estimates

August 6, 2025 | zacks.com

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

August 6, 2025 | businesswire.com

OmniAb to Report Second Quarter 2025 Financial Results on August 6

July 16, 2025 | businesswire.com

Positive week for OmniAb, Inc. (NASDAQ:OABI) institutional investors who lost 47% over the past year

July 4, 2025 | finance.yahoo.com

Chairman of OmniAb Picks Up 3.0% More Stock

May 19, 2025 | uk.finance.yahoo.com

OmniAb, Inc. (NASDAQ:OABI) Director Steven Love Purchases 25,000 Shares

May 15, 2025 | insidertrades.com

Insider Buying: OmniAb, Inc. (NASDAQ:OABI) Director Buys 65,000 Shares of Stock

May 14, 2025 | insidertrades.com

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025 | businesswire.com

Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030?

May 10, 2025 | insidermonkey.com

OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript

May 10, 2025 | msn.com

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OABI, NVRI, NEO, and FVRR Company Descriptions

Fiverr International NYSE:FVRR

$23.15 -0.40 (-1.70%)

Closing price 03:59 PM Eastern

Extended Trading

$22.98 -0.17 (-0.75%)

As of 07:57 PM Eastern

Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes various categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers value-added products, including subscription-based content marketing, back-office, learning and development offerings, creative talent, and freelancer management platforms. In addition, the company provides a suite of professional solutions that enable businesses to engage with freelancers; Fiverr Pro, a marketplace; Fiverr Certified, a storefront to access certified experts for partner vendors; Fiverr Enterprise, a gateway to source and manage on-demand and long-term freelancers. Further, it offers various value-added products, including Promoted Gigs which allows sellers to advertise their services on the platform; and Seller Plus, a subscription program that equips sellers with advanced tools. The company's buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and agencies. Fiverr International Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

NeoGenomics NASDAQ:NEO

$8.81 +0.03 (+0.34%)

Closing price 04:00 PM Eastern

Extended Trading

$8.90 +0.08 (+0.96%)

As of 07:40 PM Eastern

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Enviri NYSE:NVRI

$10.98 -0.32 (-2.79%)

Closing price 03:59 PM Eastern

Extended Trading

$10.90 -0.08 (-0.73%)

As of 04:36 PM Eastern

Enviri Corporation provides environmental solutions for industrial and specialty waste streams in the United States and internationally. The company operates through two segments: Harsco Environmental and Clean Earth. The Harsco Environmental segment offers on-site services under long-term contracts for material logistics, product quality improvement, and resource recovery for iron, steel, and metals manufacturing; manufactures and sells industrial abrasives, roofing granules, aluminum dross, and scrap processing systems; and meltshop and furnace services, such as under-vessel cleaning, removal of ladle slag, and general melt shop debris. This segment also produces and sells value-added downstream products from industrial waste-stream, including road surfacing and materials, such as slag-based asphalt product under the SteelPhal brand; abrasives and roofing materials under the BLACK BEAUTY and SURE/CUT brand names; Metallurgical Additives; agriculture and turf products comprising soil conditioners and fertilizers under the CrossOver and AgrowSil brands; and cement additives. The Clean Earth segment provides specialty waste processing, treatment, recycling, and beneficial reuse solutions for waste needs, such as hazardous, non-hazardous, and contaminated soils and dredged materials to industrial, retail, healthcare, and construction industries. The company was formerly known as Harsco Corporation and changed its name to Enviri Corporation in June 2023. The company was founded in 1853 and is headquartered in Philadelphia, Pennsylvania.

OmniAb NASDAQ:OABI

$1.58 -0.02 (-1.25%)

Closing price 04:00 PM Eastern

Extended Trading

$1.72 +0.14 (+8.54%)

As of 07:28 PM Eastern

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time